Trial Profile
Phase III trial of controlled-release interferon alpha 2B (Locteron) in patients with hepatitis C.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2011
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Hepatitis C
- Focus Registrational; Therapeutic Use
- 03 Aug 2011 New trial record